ATS 2019 Virtual Final Program

P972 Thyroid Gland in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol/ S.J. Abughazaleh, Z. Safdar, Houston, TX, p.A3628 P973 All Jerky Movements Are Not Seizures: An Atypical Presentation of Massive Pulmonary Embolism/ A. Umar, E.Y. Chang, M. Bilal, M.E. Faquih, T. Ajose, C. Bradley, Atlanta, GA, p.A3629 P974 Catch Me If You Can: Clot in Transit/ K. Sherwani, K. Uddin, P. Gurung, D. Engelman, M.A. Tidswell, Springfield, MA, p.A3630 P975 Successful Patent Foramen Ovale Closure in a Patient with Pulmonary Arterial Hypertension of Sickle Cell Disease/ C. Cramer-Bour, E.S. Klings, Boston, MA, p.A3631 Facilitator : M.J. Ryan, MD, San Luis Obispo, CA P976 Pulmonary Hypertension Due to Partial Anomalous Pulmonary Venous Return/ M. Abidali, A. Fadda, R. Saggar, Phoenix, AZ, p.A3632 P977 A Case of Persistent Left Superior Vena Cava/ F. Ogundipe, A. Thomas, Washington, DC, p.A3633 P978 A Young Woman with Chronic Dyspnea After Deep Venous Thrombus Without Pulmonary Embolus/ J.T. Powner, V.G. Valentine, Birmingham, AL, p.A3634 P979 Bilateral Pulmonary Vein Stenosis After Catheter-Based Ablation for Atrial Fibrilation: Case Report/ I.V. Lamboy-Hernandez, J.R. Aleman-Ortiz, K. Mendez-Ramirez, G.M. Gonzalez-Santiago, Ponce, Puerto Rico, p.A3635 P980 A Case Report of Pulmonary Tumor Emboli Due to an Undifferentiated Primary Tumor/ J. Kornfield, M. Miller, A.K. Brady, Portland, OR, p.A3636 P981 Is There a Paved Path Between the Lungs and Back Bone?/ R. Mandru, H. Grewal, I.G. Amzuta, C. Martinez-Balzano, Syracuse, NY, p.A3637 P982 Living in the Clouds: A Rare Cause of Pulmonary Hypertension/ A. DeMaio, K. Hena, New York, NY, p.A3638 P983 A Fortunate Accident: The Unveiling of Factor G20210A Mutation in an Otherwise Healthy Female/ A.E. Reyes Esteves, N.M. Zamot, G. Ferrer, F. Hernandez, H. Vazquez, Aventura, FL, p.A3639 P984 Pulmonary Arterial Hypertension Diagnosed 19-Years After Liver Transplant: What Is the Culprit?/ B.A. Jalil, K. El-Kersh, Louisville, KY, p.A3640 CLINICAL THEMATIC POSTER SESSION B55 USE YOUR ILLUSION I: CLINICAL RESEARCH IN PAH 9:15 a.m. - 4:15 p.m. KBHCCD Area G (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : R.L. Benza, MD, Pittsburgh, PA P986 Interstitial Lung Disease and Pulmonary Hypertension in Systemic Sclerosis: A Real-World Experience/ R. Sangani, N. Schoenberg, C. Chen, K. Dukes, E.S. Klings, Boston, MA, p.A3641 P987 Pulmonary Hypertension in a Nonreferral Setting in the Netherlands: Incidence and Patient Characteristics in the Optics Registry/ S. Jansen, A.E. Huis in ‘t Veld, P.C.G. Tolen, W. Jacobs, H.P. Grotjohan, W. Waskowsky, J. van der Maten, A. van der Weerdt, R. Hoekstra, M. Overbeek, S. Mollema, L.H. Hassan el Bouazzaoui, J. Vriend, M. Roorda, R. de Nooijer, I. van der Lee, A.J. Voogel, C. Peels, J.G. Aerts, M. Van De Ven, F. De Man, A. Vonk Noordegraaf, H.J. Bogaard, Amsterdam, Netherlands, p.A3642 P988 Right and Left Pulmonary Artery Dilation in Pulmonary Hypertension/ S. Ansari, I. de La Bruere, I. Singh, C.E. Come, M. Faria Urbina, J. Leopold, A. Hunsaker, R. San Jose Estepar, G.R. Washko, D.M. Systrom, A.B. Waxman, F.N. Rahaghi, Salem, MA, p.A3643 P989 Volatile Organic Compounds in Exhaled Breath of Patients with Pulmonary Arterial Hypertension: A Comparative Analysis/ B.A. Jalil, Z. Xie, Q. Li, X.-A. Fu, K. El-Kersh, Louisville, KY, p.A3644 P990 PAH Patients Have Upregulated SPARC in Exosomes Compared to Controls/ J. Seyfang, S. Maiolo, R. Harper, D. Greening, C. Bonder, P.N. Reynolds, Adelaide, Australia, p.A3645 Facilitator : J.A. Mazurek, MD, Philadelphia, PA P991 Changing Demographics of Patients with Idiopathic Pulmonary Arterial Hypertension (IPAH)/ A. Bhardwaj, N. Al-Naamani, D. Pinder, K. Boyle, A. McCormick, M. Patel, C.A. Burwell, A. Smith, J.A. Mazurek, C.L. Archer-Chicko, H.I. Palevsky, J.S. Fritz, S. Pugliese, S.M. Kawut, Philadelphia, PA, p.A3646 P992 Outcomes of Pulmonary Artery Aneurysms in Patients with Pulmonary Hypertension. A Single Center Experience/ A. Bhardwaj, K. Srinivasan, V. Pasricha, N.A. Kaur, K. Laothamatas, C.A. Diamond, F.M. Talebi, D. Gorman, C.L. Archer-Chicko, H.I. Palevsky, Philadelphia, PA, p.A3647 P993 Screening for Pulmonary Arteriovenous Malformation (PAVM) in Hereditary Hemorrhagic Telagiectasia: Clinical Significance of Pulmonary Micronodules and/or Positive TTCE Without PAVM/ V. Margelidon-Cozzolino, C. Khouatra, D. Gamondes, K. Ahmad, J. Traclet, S. Dupuis-Girod, V. Cottin, Lyon (Bron), France, p.A3648 P994 Risk Stratification Using Noninvasive Parameters: A Post Hoc Analysis of the TRIUMPH and FREEDOM-C2 Studies/ A.R. Tonelli, S. Sahay, K. Gordon, L. Edwards, A.G. Allmon, A. Nelsen, Cleveland, OH, p.A3649 P995 Additional Role of Unmodifiable Risk Factors in Pulmonary Arterial Hypertension Risk Stratification According to Current ESC/ERS Guidelines/ F. Dardi, A. Manes, M. Palazzini, E. Gotti, A. Rinaldi, E. Monti, E. Zuffa, D. Guarino, A. De Lorenzis, F. Pasca, I. Magnani, M. Rotunno, N. Galié, Bologna, Italy, p.A3650 ATS 2019 • Dallas, TX 174 MONDAY • MAY 20